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Summary To investigate whether the high frequency of human papillomavirus infection in butchers may be
linked to their higher than average incidence of lung cancer, we have examined lung cancers from 40 butchers
and 26 controls for the presence of DNA from both HPV type 7, which is found almost uniquely in hand
warts from butchers and fishermen, and for those HPV types associated with laryngeal and genital cancers. No
HPV 7, and only a low frequency of HPV DNA was found, suggesting that HPV infection does not make an
important contribution to the elevated levels of lung cancer in meat handlers. In addition, the frequency of
p53 mutation was shown to be slightly lower than previously reported in lung cancers.
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Butchers and slaughterman are reported to have an unusually
high incidence of lung cancer. The evidence for this comes
from analyses of occupational mortality, cancer registrations,
case-control and cohort studies, and it is remarkably consis-
tent, although there are some conflicting reports (Coggon et
al., 1989). The reasons for the raised incidence are unclear. It
may occur because meat workers smoke more than average,
but an occupational hazard is also possible (Johnson, 1994).
In particular, it has been proposed that a papillomavirus is
responsible (Benton, 1994).
Viral warts are abnormally common on the hands of but-
chers (Litt, 1969; de Peuter et al., 1977), and much if not all
of the excess prevalence is attributable to infection by the
papillomavirus, HPV 7 (Orth et al., 1981; Ostrow et al., 1981;
Rudlinger et al., 1989). This virus, which rarely causes warts
other than in butchers (Melchers et al., 1993; Keefe et al.,
1994a), has closest sequence homology and phylogenetic
similarity (van Ranst et al., 1992; Delius and Hoffman, 1994)
to both HPV 40 (also a member of HPV group F) and the
HPVs (particularly HPV 11) which are associated with
benign and malignant disease of the urogenital tract, namely
HPVs 6, 11, 16, 18, 33 and 35 (zur Hausen, 1988). In this
respect it is similar to HPV 2, which is capable of infecting
keratinised and non-keratinised epithelium (Orth et al., 1977;
de Villiers et al., 1985; Adler-Storthz et al., 1986; Greenspan
et al., 1988). HPVs in this 'mucosal' group are regularly
detected in benign and malignant lesions of the upper res-
piratory tract, and have occasionally been found in lung
tumours (Mounts and Shah, 1984; Levi et al., 1989; Carey et
al., 1990; Guillon et al., 1991; Yousem et al., 1992). HPV 7
has not been detected in lung cancer to date, but there is
clear evidence that it can infect oral mucosa as it has been
detected in oral lesions in patients with acquired immuno-
deficiency syndrome (AIDS) (Greenspan et al., 1988; Syr-
janen et al., 1989).
To test the hypothesis that papillomaviruses, and speci-
fically HPV 7, are a cause of lung cancer in meat workers, we
have determined the prevalence of HPV DNA from a
number of human papillomaviruses in archival sections of
butchers' lung carcinoma as compared with-lung cancer spec-
imens from non-butchers. In addition, we have looked for
the presence of p53 mutations in the same tumours. Such
mutations are frequently found in bronchial carcinoma
(Chiba et al., 1990) but are often absent in HPV-associated
cancers (Crook et al., 1991; Busby-Earle et al., 1994).
Materials and methods
Source of tumour specimens
The Office of Population Censuses and Surveys provided us
with copies of the death certificates7of all male butchers who
had died of lung cancer in England and Wales during 1987
and 1988 (n = 185). By contacting the hospital where the
subject had died or the doctor who had signed the death
certificate, we sought archived histological material from the
lung tumours that had caused the deaths. Where such
material was available, we asked the pathology department
concerned to send us six 10 lm formalin-fixed, paraffin-
embedded sections, each cut with a fresh blade (some depart-
ments provided blocks from which similar sections were cut).
In addition, we asked for details of how the specimen had
been obtained, the histological diagnosis and, where it was
convenient, for material from a control patient who was also
a male with lung cancer and who was approximately the
same age and diagnosed in the same year as the index case.
Suitable material was obtained from 40 butchers and 26
controls. The ages of these subjects, the source of the speci-
mens and the histological diagnoses are summarised in Table
I. Most specimens were from bronchial biopsies, and the
most common diagnosis was squamous carcinoma. All
patients with a non-pulmonary tissue source of tumour had
histologically confirmed lung cancer.
Extraction ofDNAfromformalin-fixedparaffin-embedded
tissues
Sections offormalin-fixed and paraffin-embedded tissues were
scraped from microscope slides or removed from the sterile
tubes in which they were supplied, placed in 1.5 ml Eppen-
dorf tubes and dewaxed by addition of 400fsl of xylene. The
xylene was removed, 400 tl of 100% ethanol was added and
the pellet was vortexed for 1 min, centrifuged for 5 min at
10 000 g and the ethanol carefully pipetted off. The pellet was
dried for 15 min and 100flI of analar water was added to the
pellet followed by 100 tl of paraffin oil to cover the solution.
The tube was then boiled for 10min. 10;LI volume of this
solution contained a sufficient amount of DNA for the
polymerase chain reaction (Shibata et al., 1988).
In cases where DNA was not released by this procedure,
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extensive proteinase K digestion (100fig ml-' final concentra-
tion in 5 mM Tris-HCI, 100 mM sodium chloride, 1 mM
EDTA pH 8.0 and 0.5% sodium dodecyl sulphate) was car-
ried out before phenol extraction, boiling and subsequent
addition of the deproteinised solution to the PCR reaction.
PCR conditions
All procedures involving these sections were carried out in a
laminar flow cabinet and a master stock of PCR reaction mix
containing 100 mM Tris-HCI pH 8.3, 500 mM potassium
chloride, 200 !iM each of dATP, dCTP, dGTP and dTTP Taq
DNA polymerase (NBL) (2.5 units per 100jil reaction) and
an optimised magnesium concentration was also prepared in
a separate hood. For each virus-specific reaction, the master
mixture also contained appropriate 20 bp primer pairs (Table
II) at a final concentration of 0.2,LM. The master mix was
aliquoted into 90 tll in separate Eppendorf tubes and overlaid
by addition of paraffin oil.
Specific magnesium chloride concentrations were optimised
for each of the PCR primer pairs used in the reaction, and
these are listed together with the DNA sequences for these
Table I
Butchers Controls
Number of subjects 40 26
Age (years)
Mean 65.2 66.4
Range 43-73 48-76
Source of specimen (no. of subjects)
Bronchial biopsy 19 16
Lung biopsy 4 1
Surgical resection 7 4
Autopsy 4 4
Pleural biopsy 1 0
Mediastinal biopsy 1 0
Liver biopsy 2 0
Tonsillar biopsy 1 0
Unknown 1 1
Histological diagnosis (no. of subjects)
Squamous carcinoma 19 14
Adenocarcinoma 2 2
Oat cell carcinoma 1 3
Other carcinoma 5 0
Unavailable 13 7
primers in Table II. Volumes of 10pl of extracted tissues
were mixed with 90 p1 of reaction mixture containing the
above components, and transferred to a Perkin Elmer Cetus
model 480 thermal cycler and treated as follows: denatura-
tion at 94°C for 3 min, followed by 30 cycles of 94°C for
1 min, 55°C for 1 min, 72°C for 1 min and a final extension
at 72°C for 7 min.
After the amplification reaction, S p1l from the 100l.l reac-
tion mixture was loaded on to a 1.5% agarose gel containing
0.5 fgml1 ethidium bromide and the presence of PCR pro-
ducts assessed by UV fluorescence after electrophoresis. To
intensify questionable positives, the DNA was transferred
from the agarose gel on to a Hybond N+ membrane filter
(Amersham International) following the manufacturer's in-
structions and hybridised in Amersham rapid hybridisation
buffer for 1 h, again following the manufacturer's instruc-
tions, with a 32P end-labelled 40 bp oligonucleotide which
was internal to the two PCR primer sites (Maitland and
Lynas, 1991).
Single-strand conformational polymorphism (SSCP) analysis
for p53 mutation
PCR primers spanning exons 5, 7 and 8 are shown in Table
II. A separate 10 Ll sample from each of the extracted sec-
tions of lung cancer was subjected to PCR under standard
conditions with these primers and all the products again
separated by gel electrophoresis. From positive electro-
phoresis samples 5 il was taken and reamplified for a further
ten cycles in a PCR reaction mixture depleted in unlabelled
dCTP and containing 2.5 Is Ci of [32P]dCTP (Amersham code
no. PB 10219). The PCR reaction was terminated after ten
cycles and the LI of the reaction mixture (from a total of
25ftl) was mixed with 9 p1 of sample buffer (0.1% SDS,
10 mM EDTA). Five microlitres of this mixture was then
mixed with an equal volume of formamide loading dye (95%
formamide, 20 mM EDTA, 0.5% bromophenol blue and
0.05% xylene cyanol). The samples were heated to 85°C for
5 min, chilled on ice and 4-5 IL was then loaded on to the
SSCP gel.
SCCP gel analysis
The native polyacrylamide gel analysis for single-strand con-
formational polymorphism analysis was carried out essen-
tially as described by Hayashi (1991). Initial results were
obtained using 5% polyacrylamide gels containing 10%
glycerol and 1 x TB buffer (89 mM Tris-borate, 2 mM
Table II Sequences of oligonucleotide primers
Optimal Size of
Mg++ amplification
Primer type Sequence 5'-3' Location (mM) product (bp)
HGPRT (A) CTTGCTGGTGAAAAGGACCC Exon 7-exon 8
HGPRT (B) GTCAAGGGCATATCCTACAA Exon 7-exon 8 4.5 267
p53 exon 5 (L) CCTGCCCTCAACAAGATGTT 596-616
p53 exon 5 (R) CCTCACAACCTCCGTCATGT 716-736 1.5 140
p53 exon 7 (L) GGCTCTGACTGTACCACCAT 890-910
p53 exon 7 (R) GGAGTCTTCCAGTGTGATGA 974-994 1.5 101
p53 exon 8 (L) ATCTACTGGGACGGAACAGC 1002-1122
p53 exon 8 (R) GAGAGGAGCTGGTGTTGTTG 1140-1160 4.5 249
Pan HPV (L) TGGTACAATGGGCATATGAT El
Pan HPV (R) AATGGCTTTTGGAATTTACA El 3.5 444
HPV 7 (L) AATTACTTATGACAATCCTG L2
HPV 7 (R) GACGTGTATATATGGTTCAC L2 4.5 171
HPV 6b (L) GCTAATTCGGTGCTACCTGT E6 gene
HPV 6b (R) CTGGACAACATGCATGGAAG E6 gene 1.5 140
HPV 11 (L) CGCAGAGATATATGCAATATG E6 gene
HPV 11 (R) AGTTCTAAGCAACAGGCACA E6 gene 4.5 90
HPV 16 (L) TCAAAAGCCACTGTGTCCTG E6 gene
HPV 16 (R) CGTGTTCTTGATGATCTGCA E6 gene 3.5 120
HPV 18 (L) ACCTTAATGAAAAACCACGA E6 gene
HPV 18 (R) CGTCGTTGGAGTCGTTCCTG E6 gene 1.5 100
L, left (5') primer; R, right (3') primer; HGPRT, human hypoxanthine guanine phosphoribosyl
transferase. Pan-HPV is GP1/GP2 (Van den Brule, 1993).HPV and p53 in butchers' lung cancers
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EDTA pH 8.1). Electrophoresis was carried out at 40 W,
18°C. Some of the data were obtained using 5% glycerol and
0.5 x TB as described by Orita et al. (1989). After electro-
phoresis the native polyacrylamide gel was dried and sub-
jected to autoradiography at -70°C with Dupont Cronex
Lightning plus intensifying screens for 16-48 h.
DNA sequencing
Since, at the start of this work, only very limited DNA
sequence information was available for HPV 7, we obtained
the reference clone from E-M de Villiers and H zur Hausen,
German Cancer Research Centre, Heidelberg (Oltersdorf et
al., 1986), and sequenced portions of it as a series of overlap-
ping fragments (approximately 2 kb in total) initiating from
a
b
1 2 3 4 i + M
C
primers within the pBR322 cloning vector using Taq cycle
sequencing (US Biochemical). These sequences encoded the
HPV 7 El and L2 genes (by comparison with HPV 11) and
were used as the basis for HPV 7 PCR primer design, with
the Primer Designer program (Scientific and Technical Soft-
ware, State Line, PA, USA). The fidelity of these sequences
and their coding potential has recently been confirmed by Dr
H Delius, who has completely sequenced the same HPV 7
clone (Delius and Hoffman, 1994). Taq cycle sequencing was
also used to confirm the presence of p53 mutations detected
by SSCP.
Results
Detection ofhuman papillomaviruses in tumours
The 66 tumour samples were examined for the presence of
various types of HPV DNA using PCR. The El consensus
primers shown in Table II produced an amplification product
of 444 bp. Six samples (three from butchers and three from
controls) were shown to be positive with these El primers, an
example of which is shown in Figure la and the complete
data summarised in Table III. We subsequently employed
primers specific for HPV types 6, 7, 11, 16 and 18 on these
samples. DNA from the oncogenic HPV 16 was demon-
strated in one control lung cancer, while benign type HPV
DNA was found in three subjects: one butcher and one
control with HPV 11, and a further control with both HPV 6
and 11 (Figure Ib). Two butchers positive for the consensus
El primer (van den Brule et al., 1993) showed no PCR
products when examined by the type-specific primer method,
which suggested the presence of an unusual or new HPV type
in these samples. All of the samples were tested with HPV
7-specific primers which had previously been shown (Keefe et
al., 1994a) to react specifically with HPV type 7 in hand
warts from butchers, but HPV 7 DNA was not found in any
of the tumours (Figure Ic). The ability of all of the DNA
extracts to act as a template for PCR was verified by a
positive result with primers for the human HPRT gene (data
not shown) and by a positive result (Table III) for the p53
exon-specific primers.
1 2 3 4 5 6 7 8 9 +
Figure 1 Detection of HPV DNA in lung cancer biopsy material
by consensus and type-specific PCR. (a) Consensus primer-
positive results (lanes 5, 11 and 16 contain the 444bp product
indicated by 0). (b) HPV 11 type-specific primers with positive
signals in lanes 2, 3 and 5 (90 bp product indicated by *). (c)
HPV 7-specific primers showing no positive results in the lung
samples (171 bp product indicated by 0). Size markers are (a)
0x174 RF DNA digested with HinfI and (b and c) 100 bp ladder.
Table III Summary ofHPV DNA and p53 mutation detection in lung
cancers
Butchers Non-butchers
HPV pS3 HPV p53
Confirmed histology DNA mutation DNA mutation
Squamous cell carcinoma 2/21 3/21 1/12 2/12
Adenocarcinoma 0/2 0/2 0/2 0/2
Oat cell carcinoma 0/1 0/1 0/3 0/3
Non-small cell carcinoma 0/1 0/1 - -
Unconfirmed carcinoma 1/15 4/15 2/9 0/9
(mostly SCC)
Totals 3/40 7/40 3/26 2/26
Figure 2 SSCP detection of point mutations in p53 gene exon 5.
Arrows indicate the position of mutant strand mobilities in lane
3, which also contains a copy of the normal allele. The +
indicates DNA from normal human epithelium.
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Detection ofp53 mutations in lung cancers
We also tested for p53 mutation, which has been suggested as
an important mutagenic step in the development of lung
cancers. Specific primers for exons 5, 7 and 8, which should
encompass approximately 80% of p53 mutations detected to
date in lung cancers (Hollstein et al., 1994), were used in the
PCR amplification. The average frequency of p53 mutations
in exon 6, the only other significant hotspot, is about 13% in
lung cancers. Because of shortage of material and the
requirement to use the same samples for both HPV detection
and p53 detection, the total number of samples amplified for
all the p53 primers in this group was only 46.
After PCR amplification of exons 5, 7 and 8 of p53,
abnormal SSCP mobilities, implying gene mutations, were
observed in nine (six squamous carcinomas and three
tumours for which no detailed histology report was
available). Seven mutations were found in exon 5, two in
exon 7 and none in the region containing exon 8 (sum-
marised in Table III). An example of the p53 amplification
and SSCP is shown in Figure 2. This shows a clear shift in
the pattern of fragment mobility on the SSCP gel after
denaturation and refolding of the DNA fragments. All of the
potential p53 mutations were confirmed by direct DNA
sequencing of the PCR products, and in all cases substantial
signal from the normal allele was also present, which
indicated that most of the tumours were mutant/normal
heterozygotes. No individual tumour sample in which a p53
mutation was detected (9/46) also contained HPV DNA (6/
46). Given the low positive rates, however, this is not statis-
tically significant.
Discussion
This study provides no evidence that HPV 7 or the other
HPVs tested are important causes of lung cancer in butchers.
The initial screen, using a consensus primer pair, showed that
only a small proportion of lung tumours contained HPV
DNA. This is entirely in agreement with previous work
(Bejui-Thiviolet et al., 1990) and another recent PCR-based
study of lung cancers from the general population (Shamanin
et al., 1994). The PCR method that we used is sensitive
enough to detect between one and five viral genomes in a
large excess of cellular DNA, but only six cases of HPV
infection were found, and further studies with type-specific
primers detected no evidence of HPV 7. HPV 7 is so com-
mon in butchers that most of the butchers studied are likely
to have been exposed to the virus. In a recent survey, 34% of
a butcher population had a history of wart infection (Keefe
et al., 1994a). From this we would estimate that some
15-25% of them would have had HPV 7-associated hand
warts at some stage in their working lives. Moreover, if HPV
7 were the explanation for the more than 50% excess of lung
cancer that has been reported in butchers, then this virus
would have been expected in at least 13 of the 40 butchers'
tumours examined.
It remains possible that HPV 7 could initiate the car-
cinogenic process in a 'hit and run' fashion, and not be
present or expressed in the resulting tumour. This mechanism
has been proposed in bovine alimentary tract carcinomas, in
which BPV4 is detected in non-malignant papillomas,
whereas viral DNA is completely absent in the tumours
which develop as a consequence of the action of a chemical
co-carcinogen (Campo et a!., 1985). Since we have not
studied putative precursor lesions, we cannot eliminate this
possibility for HPV 7. Also, since our PCR primers for HPV
7 detection were located in the L2 open reading frame
(ORF), a region which is frequently eliminated from high-
risk HPV types in cervical cancer upon integration into the
cell chromosome, we cannot eliminate the possibility that
only the HPV 7 E6 and E7 ORFs for example have been
retained in the butchers' tumours. However, in cervical
tumour biopsies, between 30% and 90% of cases contained
episomal full-length HPV genomes along with the integrated
viral genes (Fuchs et al., 1989; Matsukara et al., 1989; Kris-
tiansen et al., 1994). If the same situation were to apply in
the butchers' tumours, then at least a proportion of the
carcinomas would have retained the L2 ORF of HPV 7, were
it an important aetiological agent.
Mutations in the p53 gene were detected by SSCP analysis
in 22% of the butchers and 9.5% of the controls. Previous
studies suggest that at least 50% of lung cancers have p53
mutations (Chiba et al., 1990; Charles et al., 1991; Takahashi
et al., 1992). Given that SSCP is capable ofdetecting approx-
imately 80% ofpotential mutations (Hayashi, 1991) and that
the three exons chosen should account for up to 80% of
those discovered to date in the p53 genome in lung cancers
(Caron de Fromental and Soussi, 1992; Hollstein et al.,
1994), the method we used is likely to detect about 60% of
any p53 mutations that are present (Dunn et al., 1993), so
about 30% of the samples should have been affected, rather
more than we detected. The low frequency could be
accounted for either by an abnormally high prevalence of
butcher-specific mutations outwith exons 5, 7 and 8 (for
example in exon 6, since this exon was not included in the
screen) or by a targeted mutation in a base for which SSCP
is ineffective at mutant detection, or simply by the fact that
p53 mutations are less frequent in this group oflung cancers.
Perhaps the most likely explanation is dilution of the mutant
allele with an excess of normal cells in the tissue sections.
Urogenital cancers associated with HPV infection usually
contain wild-type p53 rather than mutant p53 (Crook et al.,
1991) although not inevitably so (Busby-Earle et al., 1994).
In our study no HPV DNA-positive carcinoma contained a
detectable p53 mutation. The p53 protein can be bound and
its degradation accelerated by the HPV E6 protein from
high-risk HPV types (Scheffner et al., 1993), but the low level
of HPV detection in this study indicates that HPV infection
is probably not the reason for the lower frequency of p53
mutation observed. Interestingly, both p53 mutation and
HPV detection were confined to squamous cell carcinoma
and were completely absent from samples of normal lung
(data not shown) and other histological types of tumour,
although the numbers of non-squamous cell carcinomas were
small.
If HPV 7 is not commonly associated with lung cancer in
butchers then how can the apparent excess of cases be
explained? In a recent study (Keefe et al., 1994a, b) we found
a 50% prevalence of smoking in a sample of 486 butchers.
This is higher than in the general population of Britain
(average around 33%), and high rates of smoking might
account for the raised incidence oflung cancer. Alternatively,
there could be a chemical carcinogen in the workplace (John-
son, 1994). Possible candidates include the polycyclic
aromatic hydrocarbons produced when meat is smoked, nit-
rites used in the preservation of some meats and fumes from
plastic used to wrap meat. However, current epidemiological
evidence does not point strongly to any of those as the
culprit.
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